Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flucloxacillin vs flucloxacillin + phenoxymethylpenicillin for uncomplicated cellulitis
2008-006151-42Phase 4Completed
- Sponsor
- Beaumont Hospital Dublin
- Start
- Dec 2008
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cellulitis and skin and soft tissue infections (SSTIs) comparing Flucloxacillin monotherapy with Flucloxacillin + phenoxymethylpenicillin (2 arms). Primary endpoint: Clinical cure. Started Dec 2008; status: completed.
02
Drugs
flucloxacillinphenoxymethylpenicillin
03
Conditions
cellulitisskin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on 2008-006151-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006151-42.